Related references
Note: Only part of the references are listed.Metformin and Dipeptidyl Peptidase-4 Inhibitor Differentially Modulate the Intestinal Microbiota and Plasma Metabolome of Metabolically Dysfunctional Mice
Paul M. Ryan et al.
CANADIAN JOURNAL OF DIABETES (2020)
Metformin and gut microbiota: their interactions and their impact on diabetes
Natalia G. Vallianou et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2019)
Taiwan's National Health Insurance Research Database: past and future
Cheng-Yang Hsieh et al.
CLINICAL EPIDEMIOLOGY (2019)
Administration of Akkermansia muciniphila Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice
Xiaoyuan Bian et al.
FRONTIERS IN MICROBIOLOGY (2019)
Immunomodulating Activity and Therapeutic Effects of Short Chain Fatty Acids and Tryptophan Post-biotics in Inflammatory Bowel Disease
Edda Russo et al.
FRONTIERS IN IMMUNOLOGY (2019)
History of Inflammatory Bowel Diseases
Giovanni Clemente Actis et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects
Muhamad Noor Alfarizal Kamarudin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Metformin Inhibits Epithelial-to-Mesenchymal Transition of Keloid Fibroblasts via the HIF-1α/PKM2 Signaling Pathway
Rui Lei et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2019)
Metformin protects against intestinal barrier dysfunction via AMPKα1-dependent inhibition of JNK signalling activation
Jun Deng et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Information bias in epidemiological studies with a special focus on obstetrics and gynecology
Ulrik S. Kesmodel
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2018)
Long-term treatment with metformin in type 2 diabetes and vitamin D levels: A post-hoc analysis of a randomized placebo-controlled trial
Mattijs Out et al.
DIABETES OBESITY & METABOLISM (2018)
Inflammatory bowel disease and immunonutrition: novel therapeutic approaches through modulation of diet and the gut microbiome
Larissa S. Celiberto et al.
IMMUNOLOGY (2018)
Implications of AMPK in the Formation of Epithelial Tight Junctions
Pascal Rowart et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Metformin Protects against LPS-Induced Intestinal Barrier Dysfunction by Activating AMPK Pathway
Weiche Wu et al.
MOLECULAR PHARMACEUTICS (2018)
Activating AMPK to Restore Tight Junction Assembly in Intestinal Epithelium and to Attenuate Experimental Colitis by Metformin
Lu Chen et al.
FRONTIERS IN PHARMACOLOGY (2018)
Metformin and Autoimmunity: A New Deal of an Old Drug
Francesco Ursini et al.
FRONTIERS IN IMMUNOLOGY (2018)
Population-based cohort study on comparative effectiveness and safety of biologics in inflammatory bowel disease
Riccardo Di Domenicantonio et al.
CLINICAL EPIDEMIOLOGY (2018)
Glucagon-like peptide-1 exerts anti-inflammatory effects on mouse colon smooth muscle cells through the cyclic adenosine monophosphate/nuclear factor-κB pathway in vitro
Ahmed Al-Dwairi et al.
JOURNAL OF INFLAMMATION RESEARCH (2018)
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
Siew C. Ng et al.
LANCET (2017)
A story of metformin-butyrate synergism to control various pathological conditions as a consequence of gut microbiome modification: Genesis of a wonder drug?
Kunal Maniar et al.
PHARMACOLOGICAL RESEARCH (2017)
Introduction to the Analysis of Survival Data in the Presence of Competing Risks
Peter C. Austin et al.
CIRCULATION (2016)
Metformin and the gastrointestinal tract
Laura J. McCreight et al.
DIABETOLOGIA (2016)
Exenatide and metformin express their anti-inflammatory effects on human monocytes/macrophages by the attenuation of MAPKs and NFκB signaling
Lukasz Buldak et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2016)
Metformin Improves Ileal Epithelial Barrier Function in Interleukin-10 Deficient Mice
Yansong Xue et al.
PLOS ONE (2016)
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
Peter C. Austin et al.
STATISTICS IN MEDICINE (2015)
Metformin Ameliorates Inflammatory Bowel Disease by Suppression of the STAT3 Signaling Pathway and Regulation of the between Th17/Treg Balance
Seon-Yeong Lee et al.
PLOS ONE (2015)
The performance of different propensity score methods for estimating marginal hazard ratios
Peter C. Austin
STATISTICS IN MEDICINE (2013)
Cellular and molecular mechanisms of metformin: an overview
Benoit Viollet et al.
CLINICAL SCIENCE (2012)
Investigation of the effect of oral metformin on dipeptidylpeptidase-4 (DPP-4) activity in Type 2 diabetes
J. Cuthbertson et al.
DIABETIC MEDICINE (2009)
Metformin treatment of rats with diet-induced overweight and hypertriglyceridemia decreases plasma triglyceride concentrations, while decreasing triglyceride and increasing ketone body output by the isolated perfused liver
Paolo Tessari et al.
ACTA DIABETOLOGICA (2008)
Gastroenterology 1 - Inflammatory bowel disease: cause and immunobiology
Daniel C. Baumgart et al.
LANCET (2007)
Share Paper
